Reported 4 months ago
Gilead Sciences, Inc. (GILD) is highlighted as one of the top stocks to buy according to Jim Simons’ Renaissance Technologies, ranking 10th on their list. Despite a slight decline in total product sales, Gilead's core business remains strong, particularly in HIV treatments, which account for a significant portion of its revenue. The company also plans to invest $11 billion to enhance its manufacturing and research capabilities in the U.S. However, some experts suggest that certain AI stocks may offer higher potential for returns compared to Gilead.
Source: YAHOO